China's SFDA Sets New GMP Inspectional Guidelines
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State Food and Drug Administration issued revised good manufacturing practice inspectional guidelines Oct. 24 in an effort to increase quality systems standards for pharmaceutical manufacturers. The new guidelines are scheduled to go into effect Jan. 1, replacing the current GMP inspectional guidelines, which were implemented in 1998